ISO/DPAS 23307.2

Healthcare organization management — Pandemic response — Guidance for managing infected patients with respiratory infectious disease

Management des organisations de soins de santé — Réponse en cas de pandémie — Lignes directrices relatives à la prise en charge des patients atteints d'une maladie respiratoire infectieuse

General Information

• Status: Not Published
• ICS: 11.020.01 - Quality and environmental management in health care
• Technical Committee: ISO/TC 304 - Healthcare organization management
• Drafting Committee: ISO/TC 304 - Healthcare organization management

Standards Content (Sample)

FINAL DRAFT
Publicly
Available
Specification
ISO/DPAS 23307
ISO/TC 304
Healthcare organization
Secretariat: ANSI
management — Pandemic response
Voting begins on:
— Guidance for managing infected
2024-02-01
patients with respiratory infectious
Voting terminates on:
disease
2024-03-28
RECIPIENTS OF THIS DRAFT ARE INVITED TO SUBMIT,
WITH THEIR COMMENTS, NOTIFICATION OF ANY
RELEVANT PATENT RIGHTS OF WHICH THEY ARE AWARE
AND TO PROVIDE SUPPOR TING DOCUMENTATION.
IN ADDITION TO THEIR EVALUATION AS
BEING ACCEPTABLE FOR INDUSTRIAL, TECHNO­
LOGICAL, COMMERCIAL AND USER PURPOSES, DRAFT
INTERNATIONAL STANDARDS MAY ON OCCASION HAVE
TO BE CONSIDERED IN THE LIGHT OF THEIR POTENTIAL
TO BECOME STAN DARDS TO WHICH REFERENCE MAY BE
MADE IN NATIONAL REGULATIONS.
Reference number
ISO/DPAS 23307:2024(en) © ISO 2024

FINAL DRAFT
ISO/DPAS 23307:2024(en)
Publicly
Available
Specification
ISO/DPAS 23307
ISO/TC 304
Healthcare organization
Secretariat: ANSI
management — Pandemic response
Voting begins on:
— Guidance for managing infected
patients with respiratory infectious
Voting terminates on:
disease
RECIPIENTS OF THIS DRAFT ARE INVITED TO SUBMIT,
WITH THEIR COMMENTS, NOTIFICATION OF ANY
RELEVANT PATENT RIGHTS OF WHICH THEY ARE AWARE
AND TO PROVIDE SUPPOR TING DOCUMENTATION.
© ISO 2024
IN ADDITION TO THEIR EVALUATION AS
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication may
BEING ACCEPTABLE FOR INDUSTRIAL, TECHNO­
LOGICAL, COMMERCIAL AND USER PURPOSES, DRAFT
be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on
INTERNATIONAL STANDARDS MAY ON OCCASION HAVE
the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address below
TO BE CONSIDERED IN THE LIGHT OF THEIR POTENTIAL
or ISO’s member body in the country of the requester.
TO BECOME STAN DARDS TO WHICH REFERENCE MAY BE
MADE IN NATIONAL REGULATIONS.
ISO copyright office
CP 401 • Ch. de Blandonnet 8
CH-1214 Vernier, Geneva
Phone: [phone]
Email: [e-mail]
Website: www.iso.org
Published in Switzerland Reference number
ISO/DPAS 23307:2024(en) © ISO 2024

ii
ISO/DPAS 23307:2024(en)
Contents Page
Foreword .iv
Introduction .v
1 Scope . 1
2 Normative references . 1
3 Terms and definitions . 1
4 Classification of patients with respiratory infectious diseases . 2
[1]
4.1 Preliminary patient classification .2
[2]
4.2 Severity classifications based on respiratory infectious disease symptoms .2
5 Control of confirmed patients of respiratory infectious disease . 3
[1]
5.1 Control of overseas entrants .3
5.1.1 People applicable to control .3
5.1.2 Diagnostic tests .3
5.1.3 General control measures .3
[1][4]
5.1.4 Control measures for confirmed patients in the POE screening stage .4
[1][5]
5.2 Control of people in self-quarantine .4
5.2.1 Individuals subject to self-quarantine .4
[6]
5.2.2 Quarantine area and method .5
5.2.3 Recommendations on the prevention of leaving quarantine areas after
quarantine release .5
[3]
5.2.4 Temporarily leaving the quarantine area .5
5.2.5 Quarantine .5
5.3 Control of severally ill patients at the hospital .5
5.3.1 Criteria for entering treatment beds for severely ill patients .5
[7]
5.3.2 Bed allocation .6
[1][3][8][9]
6 Resource management and bed operation . 6
[9]
6.1 Operation of designated isolation bed .6
[11]
6.2 Operation of general isolation bed .6
[3]
Annex A (informative) Survey on patients with respiratory disease . 8
Bibliography .10

iii
ISO/DPAS 23307:2024(en)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out through
ISO technical committees. Each member body interested in a subject for which a technical committee
has been established has the right to be represented on that committee. International organizations,
governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely
with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are described
in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the different types
of ISO documents should be noted. This document was drafted in accordance with the editorial rules of the
ISO/IEC Directives, Part 2 (see www.iso.org/directives).
ISO draws attention to the possibility that the implementation of this document may involve the use of (a)
patent(s). ISO takes no position concerning the evidence, validity or applicability of any claimed patent
rights in respect thereof. As of the date of publication of this document, ISO had not received notice of (a)
patent(s) which may be required to implement this document. However, implementers are cautioned that
this may not represent the latest information, which may be obtained from the patent database available at
www.iso.org/patents. ISO shall not be held responsible for identifying any or all such patent rights.
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and expressions
related to conformity assessment, as well as information about ISO's adherence to the World Trade
Organization (WTO) principles in the Technical Barriers to Trade (TBT), see www.iso.org/iso/foreword.html.
This document was prepared by ISO/TC 304, Healthcare organization management.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www.iso.org/members.html.

iv
ISO/DPAS 23307:2024(en)
Introduction
This document concerns patients infected with respiratory infectious diseases with a high transmission
risk including Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and
coronavirus disease 2019 (COVID-19), requiring the isolation of patients.
Major infection routes for respiratory infectious diseases include droplets from humans (e.g. droplets
produced by the source person during breathing, talking, sneezing, coughing) or contact infection when a
person touches one’s own eyes, nose or areas surrounding the lips with their contaminated hands or after
contacting a contaminated mediator.
Such patients usually experience a high fever of 38 °C or above as the most common symptom; however, no
fever can be observed in the early stage. Coughing, dyspnea, fever, malaise, myalgia, headache, chilliness and
other symptoms can also be developed.
This document provides standardized guidance for managing infected patients in healthcare organizations
and other facilities based on the COVID-19 classification criteria of the World Health Organization (WHO) in
classifying patients infected with respiratory diseases with a high transmission risk.

v
FINAL DRAFT Publicly Available Specification ISO/DPAS 23307:2024(en)
Healthcare organization management — Pandemic response
— Guidance for managing infected patients with respiratory
infectious disease
1 Scope
This document provides recommendations for healthcare organizations on how to effectively manage and
classifies patients who are infected with respiratory infectious diseases, especially during a pandemic. It
covers various aspects of patient care, infection control and healthcare facility management to ensure the
safety of both patients and healthcare workers in such situations.
2 Normative references
There are no normative references in this document.
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
ISO and IEC maintain terminology databases for use in standardization at the following addresses:
— ISO Online browsing platform: available at https:// www .iso .org/ obp
— IEC Electropedia: available at https:// www .electropedia .org/
3.1
confirmed patient
person who is confirmed to be infected with an infectious disease pathogen according to the test criteria for
respiratory infectious disease diagnosis
3.2
asymptomatic
not showing signs or symptoms of the associated disease
[SOURCE: ISO/TS 16975-4:2022, 3.4]
3.3
symptomatic case
person who has epidemiological association with the outbreak of respiratory infectious diseases and has
associated signs or symptoms following incubation period
3.4
self-quarantine
act of staying away from others, typically at home, after possible exposure to an infectious disease, to
prevent the spread of infection

ISO/DPAS 23307:2024(en)
4 Classification of patients with respiratory infectious diseases
[1]
4.1 Preliminary patient classification
4.1.1 A preliminary classification is carried out according to the following procedure:
a) identifying clinical symptoms and risk factors;
b) determining treatment priority;
c) selecting and classifying patients who require in-patient care.
4.1.2 The preliminary system classifies patients based on the details stated in the confirmed patients
survey and patient screening questionnaire by referring to the factors considered for hospitalization by the
institutions concerned (see Annex A).
— Altered consciousness presented after the onset of respiratory disease infection symptoms.
— Dyspnea (shortness of breath in daily life).
— Fever goes 38 °C or above and lasts for more than three days, not suppressed with antipyretics.
— Diabetes uncontrolled with drugs.
— Patients with mental illness, presenting symptoms uncontrolled with drugs.
— Bedridden patients (lying in bed for more than half of day time).
— Pregnant women presenting with symptoms (including abdominal pain, pains and vaginal bleeding) and
severely ill children.
[2]
4.2 Severity classifications based on respiratory infectious disease symptoms
The severity of patients with respiratory infectious diseases should be classified as shown in Table 1,
[1]
according to the WHO COVID-19 Response Guideline.
Table 1 — Severity classifications based on respiratory infectious disease symptoms
Stage Definition Severity
0 No clinical or virologic
...

ISO /DPAS 23307:####(X)
ISO /TC 304/WG 4
Secretariat: ANSI
Date: 2023-09-302024-01-18
Healthcare organization management — Pandemic response —
Guidance for managing infected patients with respiratory
infectious disease
DPAS stage
Warning for WDs and CDs
This document is not an ISO International Standard. It is distributed for review and comment. It is subject to
change without notice and may not be referred to as an International Standard.
Recipients of this draft are invited to submit, with their comments, notification of any relevant patent rights of
which they are aware and to provide supporting documentation.

A model manuscript of a draft International Standard (known as “The Rice Model”) is available at
https://www.iso.org/iso/model_document-rice_model.pdf

© ISO #### – All rights reserved

ISO #####-#:####(X)
2 © ISO #### – All rights reserved

ISO /DPAS 23307:####(X:(en)
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication
may be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying,
or posting on the internet or an intranet, without prior written permission. Permission can be requested from either ISO
at the address below or ISO’s member body in the country of the requester.
ISO copyright office
CP 401 • Ch. de Blandonnet 8
CH-1214 Vernier, Geneva
Phone: + 41 22 749 01 11
EmailE-mail: [e-mail]
Website: www.iso.orgwww.iso.org
Published in Switzerland
© ISO #### 2024 – All rights reserved

iii
ISO /DPAS 23307:####(X:(en)
Contents
Foreword . v
Introduction. vii
1 Scope .1
2 Normative references .1
3 Terms and definitions .1
4 Classification of patients with respiratory infectious diseases .1
[1]
4.1 Preliminary patient classification .1
[2]
4.2 Severity classifications based on respiratory infectious disease symptoms .2
5 Control of confirmed patients of respiratory infectious disease .2
[1]
5.1 Control of overseas entrants .2
5.1.1 People applicable to control .2
5.1.2 Diagnostic tests .3
5.1.3 General control measures .3
[1][4]
5.1.4 Control measures for confirmed patients in the POE screening stage .4
[1][5]
5.2 Control of people in self-quarantine .5
5.2.1 Individuals subject to self-quarantine .5
[6]
5.2.2 Quarantine area and method .5
5.2.3 Recommendations on the prevention of leaving quarantine areas after quarantine release .5
[3]
5.2.4 Temporarily leaving the quarantine area .5
5.2.5 Quarantine .6
5.3 Control of severally ill patients at the hospital .6
5.3.1 Criteria for entering treatment beds for severely ill patients .6
[7]
5.3.2 Bed allocation .6
[1][3][8][9]
6 Resource management and bed operation .6
[9]
6.1 Operation of designated isolation bed .6
[11]
6.2 Operation of general isolation bed .7
[3]
Annex A (informative) Survey on patients with respiratory disease .8
Bibliography . 11

iv © ISO #### 2024 – All rights reserved

iv
ISO /DPAS 23307:####(X:(en)
Foreword
Foreword iv
Introduction v
1 Scope 1
2 Normative references 1
3 Terms and definitions 1
4 Classification of patients with respiratory infectious diseases 1
4.1 Preliminary patient classification 1
4.2 Severity classifications based on respiratory infectious disease symptoms 2
5 Control of confirmed patients of respiratory infectious disease 2
5.1 Control of overseas entrants 2
5.1.1 People applicable to control 2
5.1.2 Diagnostic tests 2
5.1.3 General control measures 3
5.1.4 Control measures for confirmed patients in the POE screening stage 3
5.2 Control of People in self-quarantine 4
5.2.1 Individuals subject to self-quarantine 4
5.2.2 Quarantine area and method 4
5.2.3 Recommendations on the prevention of leaving quarantine areas after quarantine release 4
5.2.4 Temporarilyleaving the Quarantine Area 4
5.2.5 Quarantine 5
5.3 Control of severally ill patients at hospital 5
5.3.1 Criteria for entering treatment beds of for severely ill patients 5
5.3.2 Bed allocation 5
6 Resource management and bed operation 5
6.1 Operation of designated isolation bed 5
6.2 Operation of general isolation bed 6
Annex A (informative) Survey on patients with respiratory disease 7
Bibliography 9
© ISO #### 2024 – All rights reserved

v
ISO /DPAS 23307:####(X:(en)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out through
ISO technical committees. Each member body interested in a subject for which a technical committee has been
established has the right to be represented on that committee. International organizations, governmental and
non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the
International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are described
in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the different types of
ISO documents should be noted. This document was drafted in accordance with the editorial rules of the
ISO/IEC Directives, Part 2 (see www.iso.org/directiveswww.iso.org/directives).
ISO draws attention to the possibility that the implementation of this document may involve the use of (a)
patent(s). ISO takes no position concerning the evidence, validity or applicability of any claimed patent rights
in respect thereof. As of the date of publication of this document, ISO had not received notice of (a) patent(s)
which may be required to implement this document. However, implementers are cautioned that this may not
represent the latest information, which may be obtained from the patent database available at
www.iso.org/patents.www.iso.org/patents. ISO shall not be held responsible for identifying any or all such
patent rights.
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and expressions
related to conformity assessment, as well as information about ISO's adherence to the World Trade
Organization (WTO) principles in the Technical Barriers to Trade (TBT), see
www.iso.org/iso/foreword.htmlwww.iso.org/iso/foreword.html.
This document was prepared by ISO/TC 304, Healthcare organization management.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www.iso.org/members.htmlwww.iso.org/members.html.
vi © ISO #### 2024 – All rights reserved

vi
ISO /DPAS 23307:####(X:(en)
Introduction
This document concerns patients infected with respiratory infectious diseases with a high transmission risk
including Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and
coronavirus disease 2019 (COVID-19), requiring the isolation of patients.
Major infection routes for respiratory infectious diseases include droplets from humans (e.g. droplets
produced by the source person during breathing, talking, sneezing, coughing) or contact infection when a
person touches one’s own eyes, nose, or areas surrounding the lips with their contaminated hands or after
contacting a contaminated mediator.
Such patients usually experience a high fever of 38 °C or above as the most common symptom; however, no
fever can be observed in the early stage. Coughing, dyspnea, fever, malaise, myalgia, headache, chilliness, and
other symptoms can also be developed.
This document hasprovides standardized guidance for managing infected patients in healthcare organizations
and other facilities based on the COVID-19 classification criteria of the World Health Organization (WHO) in
classifying patients infected with respiratory diseases with a high transmission risk.

© ISO #### 2024 – All rights reserved

vii
ISO/DPAS 23307:(en)
Healthcare organization management — Pandemic response —
Guidance for managing infected patients with respiratory infectious
disease
1 Scope
This document provides recommendations for healthcare organizations on how to effectively manage and
classifies patients who are infected with respiratory infectious diseases, especially during a pandemic. It
covers various aspects of patient care, infection control, and healthcare facility management to ensure the
safety of both patients and healthcare workers in such situations.
2 Normative references
There are no normative references in this document.
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
ISO and IEC maintain terminology databases for use in standardization at the following addresses:
— — ISO Online browsing platform: available at https://www.iso.org/obphttps://www.iso.org/obp
— — IEC Electropedia: available at https://www.electropedia.org/https://www.electropedia.org/
3.1
confirmed patient
person who is confirmed to be infected with an infectious disease pathogen according to the test criteria for
respiratory infectious disease diagnosis.
3.2
asymptomatic
not showing signs or symptoms of the associated disease
[SourceSOURCE: ISO/TS 16975-4:2022, 3.4]
3.3.
symptomatic case
person who has epidemiological association with the outbreak of respiratory infectious diseases and has
associated signs or symptoms following incubation period
3.4
self-quarantine
act of staying away from others, typically at home, after possible exposure to an infectious disease, to prevent
the spread of infection
4 Classification of patients with respiratory infectious diseases
[1]
4.1 Preliminary patient classification [1]
4.1.1 A preliminary classification is carried out inaccording to the following procedure:
a) identifying clinical symptoms and risk factors;
© ISO #### 2024 – All rights reserved 1

ISO/DPAS 23307:(en)
b) determining treatment priority;
c) selecting and classifying patients who require in-patient care.
4.1.2 The preliminary system classifies patients based on the details stated in the confirmed patients survey
and patient screening questionnaire by referring to the factors considered for hospitalization by the
institutions concerned (see Annex A).Annex A).
— alteredAltered consciousness presented after the onset of respiratory disease infection symptoms.
— dyspneaDyspnea (shortness of breath in daily life)).
— feverFever goes 38 °C or above and lasts for more than 3 three days, not suppressed with antipyretics.
— diabetesDiabetes uncontrolled with drugs.
...